SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-038123
Filing Date
2023-10-24
Accepted
2023-10-24 16:15:27
Documents
27

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 4041107
2 forms-1_001.jpg GRAPHIC 5044
3 forms-1_002.jpg GRAPHIC 34890
4 image_001.jpg GRAPHIC 20725
5 image_002.jpg GRAPHIC 34166
6 forms-1_004.jpg GRAPHIC 12965
7 forms-1_005.jpg GRAPHIC 13983
8 forms-1_006.jpg GRAPHIC 25725
9 forms-1_007.jpg GRAPHIC 15984
10 forms-1_008.jpg GRAPHIC 28301
11 var_001.jpg GRAPHIC 42877
12 var_002.jpg GRAPHIC 107261
13 forms-1_011.jpg GRAPHIC 28947
14 forms-1_012.jpg GRAPHIC 30130
15 forms-1_013.jpg GRAPHIC 22261
16 forms-1_014.jpg GRAPHIC 22521
17 forms-1_015.jpg GRAPHIC 17612
18 forms-1_016.jpg GRAPHIC 20759
19 forms-1_017.jpg GRAPHIC 14212
20 forms-1_018.jpg GRAPHIC 14386
21 forms-1_019.jpg GRAPHIC 16449
22 forms-1_020.jpg GRAPHIC 15674
23 forms-1_021.jpg GRAPHIC 16302
24 forms-1_022.jpg GRAPHIC 16184
25 forms-1_023.jpg GRAPHIC 23762
26 forms-1_024.jpg GRAPHIC 52025
27 forms-1_025.jpg GRAPHIC 23650
  Complete submission text file 0001493152-23-038123.txt   4977347
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-268934 | Film No.: 231342863
SIC: 2834 Pharmaceutical Preparations